| Khalisa Israt Jahan Syeda, DO | |
|
540 Westgate Pkwy, Dothan, AL 36303 | |
| (205) 934-3460 | |
| Not Available |
| Full Name | Khalisa Israt Jahan Syeda |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Pediatric Cardiology |
| Location | 540 Westgate Pkwy, Dothan, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326474438 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0202X | Pediatrics - Pediatric Cardiology | DO.2052 (Alabama) | Primary |
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
Several SARS-CoV-2 variants have emerged, posing a renewed threat to COVID-19 containment and to vaccine and drug efficacy. In this study, we analyzed more than 820,000 SARS-CoV-2 genomic sequences deposited up to March 26, 2021 and identified a novel T478K mutation located on the SARS-CoV-2 Spike protein.
Though HIV prevalence in Nepal has dropped from 0.45 percent in 2005 to 0.3 percent in 2012, according to a new report (.pdf) from the government, "poor understanding of antiretroviral therapy (ART) amongst health officials, clinicians and patients in Nepal could undermine those gains ... and threaten future progress in lowering the number of new infections," PlusNews reports.
Meda Pharmaceuticals Inc. (Meda) today announced the commercial availability of EDLUAR(TM) (zolpidem tartrate sublingual tablets) in the United States. EDLUAR is indicated for the short-term treatment of insomnia characterized by difficulties with falling asleep. EDLUAR is the first available under-the-tongue formulation of zolpidem tartrate, which is the most prescribed treatment for insomnia. Zolpidem tartrate is also the active ingredient in Ambien(R) oral tablets.
According to a study published in the August issue of the Journal of the American College of Surgeons, there was an increase in the number of laparoscopic bariatric procedures, an increase in the number of bariatric surgeons and a decrease of inhospital mortality rates between 2003 and 2008.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Khalisa Israt Jahan Syeda, DO 540 Westgate Pkwy, Dothan, AL 36303-3073 Ph: (205) 934-3460 | Khalisa Israt Jahan Syeda, DO 540 Westgate Pkwy, Dothan, AL 36303 Ph: (205) 934-3460 |
News Archive
Several SARS-CoV-2 variants have emerged, posing a renewed threat to COVID-19 containment and to vaccine and drug efficacy. In this study, we analyzed more than 820,000 SARS-CoV-2 genomic sequences deposited up to March 26, 2021 and identified a novel T478K mutation located on the SARS-CoV-2 Spike protein.
Though HIV prevalence in Nepal has dropped from 0.45 percent in 2005 to 0.3 percent in 2012, according to a new report (.pdf) from the government, "poor understanding of antiretroviral therapy (ART) amongst health officials, clinicians and patients in Nepal could undermine those gains ... and threaten future progress in lowering the number of new infections," PlusNews reports.
Meda Pharmaceuticals Inc. (Meda) today announced the commercial availability of EDLUAR(TM) (zolpidem tartrate sublingual tablets) in the United States. EDLUAR is indicated for the short-term treatment of insomnia characterized by difficulties with falling asleep. EDLUAR is the first available under-the-tongue formulation of zolpidem tartrate, which is the most prescribed treatment for insomnia. Zolpidem tartrate is also the active ingredient in Ambien(R) oral tablets.
According to a study published in the August issue of the Journal of the American College of Surgeons, there was an increase in the number of laparoscopic bariatric procedures, an increase in the number of bariatric surgeons and a decrease of inhospital mortality rates between 2003 and 2008.
› Verified 3 days ago
Dr. Craig B Adams, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 364 Honeysuckle Rd, Dothan, AL 36305 Phone: 334-794-8656 Fax: 877-389-4229 | |
Kristine Campbell Sawyer, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 126 Clinic Dr, Dothan, AL 36303 Phone: 334-793-1881 | |
Dr. Meredith Cheryl Hitch, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 5565 Montgomery Hwy, Dothan, AL 36303 Phone: 334-699-3733 Fax: 334-500-3007 | |
Dr. Sarah W Germanson, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 364 Honeysuckle Rd, Dothan, AL 36305 Phone: 334-794-8656 Fax: 877-389-4229 | |
Dr. Risha Kahlil Gatlin, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 364 Honeysuckle Rd, Dothan, AL 36305 Phone: 334-794-8656 Fax: 877-389-4229 | |
John E. Searcy, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 364 Honeysuckle Rd, Dothan, AL 36305 Phone: 334-794-8656 Fax: 334-702-7047 | |
Michelle S. Freeman, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 126 Clinic Dr, Dothan, AL 36303 Phone: 334-793-1881 Fax: 334-712-1815 |